1995
DOI: 10.1016/0264-410x(94)00027-k
|View full text |Cite
|
Sign up to set email alerts
|

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
14
0

Year Published

1996
1996
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 27 publications
2
14
0
Order By: Relevance
“…Both proteins are protected from the immune system by an outer membrane whose major components include OspA and OspB in the tick and OspC and OspD in mammals (22). When mice are immunized with a recombinant OspA, they are protected from challenge by the same strain of B. burgdorferi (11,23) but not necessarily from challenge by heterologous strains of B. burgdorferi (12,13).…”
mentioning
confidence: 99%
“…Both proteins are protected from the immune system by an outer membrane whose major components include OspA and OspB in the tick and OspC and OspD in mammals (22). When mice are immunized with a recombinant OspA, they are protected from challenge by the same strain of B. burgdorferi (11,23) but not necessarily from challenge by heterologous strains of B. burgdorferi (12,13).…”
mentioning
confidence: 99%
“…Of these Osps, OspA and OspC have been most studied. Experimental vaccines made against either of these Osps are successful in warding off challenges from the same strain [20][21][22][23]; however, a number of investigators have found that antisera raised to 1 strain do not necessarily protect against heterologous challenge [23][24][25]. Antisera raised to OspA and OspB confer protection in SCID mice [21].…”
Section: Discussionmentioning
confidence: 99%
“…The rOspA vaccine was then shown to be protective against naturally occurring tick-transmitted infection. [189][190][191] The effectiveness of rOspA vaccine initially was surprising because organisms isolated from infected animals do not express OspA until naturally occurring late infections. It was discovered that the vaccine acts primarily in the tick midgut rather than in the vaccinated host.…”
Section: Bacteriamentioning
confidence: 98%